HIV protease inhibitors, compositions containing the same,...

Details HIV protease inhibitors, compositions containing the same,... HIV protease inhibitors, compositions containing the same,...

2006-08-22

2006-08-22

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S423000, C514S315000, C546S245000

Reexamination Certificate

active

07094909

ABSTRACT:
The present invention concerns processes for preparing compounds of formula (I-H), or a prodrug, pharmaceutically active metabolite, or pharmaceutically active salt or solvate thereof,which are useful as inhibitors of the HIV protease enzyme.

REFERENCES:
patent: 5629406 (1997-05-01), Higashida et al.
patent: 5644028 (1997-07-01), Mimoto et al.
patent: 5932550 (1999-08-01), Kato et al.
patent: 5962640 (1999-10-01), Kato et al.
patent: 6222043 (2001-04-01), Kato et al.
patent: 6313094 (2001-11-01), Mimoto et al.
patent: 6329502 (2001-12-01), Mimoto et al.
patent: 2002/0049165 (2002-04-01), Mimonto et al.
patent: 2179935 (1996-12-01), None
patent: 0490667 (1992-06-01), None
patent: 0498680 (1992-08-01), None
patent: 0574135 (1993-12-01), None
patent: 587311 (1994-03-01), None
patent: 0706794 (1996-04-01), None
patent: 0751145 (1996-06-01), None
patent: 8259532 (1996-10-01), None
patent: 705193 (1997-02-01), None
patent: 10-867489 (1998-04-01), None
patent: 10101654 (1998-04-01), None
patent: 2003119137 (2003-04-01), None
patent: WO 93/13066 (1993-07-01), None
patent: WO 2002 100845 (2002-12-01), None
patent: WO 2002100844 (2002-12-01), None
patent: WO 03/035076 (2003-05-01), None
patent: WO 03/035650 (2003-05-01), None
patent: WO 03/049690 (2003-06-01), None
patent: WO 03/062204 (2003-07-01), None
patent: WO 03/062238 (2003-07-01), None
patent: WO 03/047564 (2003-12-01), None
Andres, “Stereoselective Cyanation Of Chiral α-Amino Aldehydes By Reaction With Nagata's Reagent: A Route To Enantiopure β-Amino-α-Hydroxy Acids,”Tetrahedron Asymm., 2001, pp. 347-353, vol. 12.
Blanco, M. et al., “Enantiospecific And Stereoselective Synthesis Of Polyhydroxylated Pyrrolidines And Indolizidines From Trans-4-Hydroxy-L-Proline,”J. Org. Chem. 1996, pp. 4748-4755, vol. 61.
Humphrey, J. et al., “Chemical Synthesis Of Natural Product Peptides: Coupling Methods For The Incorporation Of Noncoded Amino Acids Into Peptides,”Chemical Reviews, 1997, 2243-2266 vol. 97.
Ikunanka, et. al., “A Concise Synthesis of (2S,3S)-BocAHPBA and ®-BocDMTA, Chiral Building Blocks for Peptide-Mimetic HIV Protease Inhibitors,”Tetrahedron Asymmetry, 2002, vol. 13, 1201.
Jacques, et al.,Enantiomers, Racemates, and Resolutions, 1981, John Wiley & Sons, New York.
Larock, et al.,Comprehensive Organic Transformations, 1989, Chapter 9, New York.
Sasai, H., et al., “Diatereoselective Catalytic Asymmetric Nitroaldol Reaction Utilizing Rare Earth-Li-(R)-BINOL Complex. A Highly Efficient Synthesis Of Norstatine,”Tetrahedron Letters, 1994, pp. 6123-6126, vol. 35, No. 33.
Sharma, R. et al., “Regioselective Enolization And Alkylation Of 4-Oxo-N-(9-Phenylfluoren-9-yl)Proline: Synthesis Of Enantiopure Proline-Valine And Hydroxyproline-Valine Chimeras,”J. Org Chem. 1996, pp. 202-209, vol. 61.
Sustmann, et al.,Comprehensive Organic Synthesis, 1991, vol. 6, 301-434, Trost.
Bell, et al., “Development of Orally Active Oxytocin Antagonists: on 1-(1-(4-[1-2- Methyl-1-oxidophyridin-3-ylmethyl)piperidin-4-yloxy]-2-methoxybenzoyl)peperidin-5-yl)-1-4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines,”Journal of Medicinal Chemistry, 1998, 2146-2163, vol. 41.
Yoshiaki, Patent Abstracts of Japan, Publication No. 10182601, 1998, No. 12.
Sheha, et al.,Euro J. Med. Chem., 2000, 887-894, vol. 35, No. 10.
Kitzaki, et al.,Chem&Pharm. Bulletin, Pharm. Soc. Of Japan, 1994, 2636-2640, vol. 42, No. 12.
Slee, et al.,J.A.C.S., 1995, 11867-11878, vol., 117, No. 48.
Komai, et al.,Biorg. Med. Chem., 1996, 1356-1377, Volo. 4, No. 8.
Kiso., et al.,Arch. Pharm., Pharm. Med. Chem., 1998, 87-89, vol. 331.
Matsumoto, et al.,Biorg. Med. Chem., 2001, 417-430, vol. 9, No. 2.
Tam, et al.,J. Med. Chem., 1992, 1318-1320, vol. 35, No. 7.
Van-Duc Le, et al., “Structure-Activity of FIV and HIV Protease Inhibitors Containing Allophenylnorstatine,”Biorg. Med. Chem., 2001, 1185-1195, vol. 9.
Mimoto, et al., “Structure-Activity Relationship of Orally Potent Tripeptide-Based HIV Protease Inhibitors containing HydroxymethylCarbonyl Isotease,”Chem&Pharm. Bulletin, Pharm Soc. Of Japan, 2000, 1310-1326, vol. 48, No. 9.
Sodergren, et. al., “Allylic Alcohols Via Catalytic Asymmetric Expoxide Rearrangement,”J. Am. Chem. Soc., 2000, 6610-6018, vol. 122, No. 28.
Falorni, et. al., “Optically Active 4-Oxaproline Deriviatives: New Useful Chiral Lsynthons Derived from Serine and Threonine,” Tetrahedron: Asymmetry, 1995, 287294, vol. 6, No. 1.
Bobbitt, et. al., “Synthesis of Isoquinoline Alkaloids. II. The synthesis and Reasctions of 4-Methyl-3-pyridinecarboxaldehyde and Other 4-methyl-3-substituted Pyridines,” J. Org. Chem., 1959, 560, vol. 25.
Bundgaard,Design of Prodrugs, 1985.
Carlsen, et. al., “Thermolysis of N-Allylic 1,2,4-Triazoles,”Institute of Organic Chemistry, 1997, 797-805, vol. 34.
Charlesworth, et. al., “Phthalide Formation,”Can. J. Chem., 1963, 1071-1077, vol. 41.
Demange, et. al., “Practical Synthesis of Boc and Fmoc Protected 4-Fluoro and 4-Difluoroprolines from Trans-4-Hydrozyproline,”Tetrahedron Letters, 1998, 1169-1172, vol. 39.
Dondoni., et. al., “Total Synthesis of (+)-Galactostatin. An Illustration of the Utility of the Thizole-Aldehyde Synthesis,”J. Org. Chem.., 1995, 4749-4754, vol. 60.
Enantiomers, Racemates, and Resolutions, 1991.
Fujiwara, et. al., “Orientation in Nitration and Sulfonation of 2,5-Dimethylbenzoic Acid,”Can. J. Chem., 1970, 1346-1349, vol. 48.
Harada, et. al., “Synthesis and Resolution of -N-[1-methyl-4(3-methylbenzyl)hexahydro-1H-1,4-diazepin-6-yl]-1H-indazole-3-Carboxamide By Preferential Crystallization,”Tetrahedron Asymmetry, 1997, 2367-2374, vol. 8, No. 14.
Holzgrabe, U., “Cer(IV)sulfat-Oxidationen: Intramolekulare Cyclisierung von N-benzyl-β-Aminoketonen zu 4-Benzoyl-1,2,3,4-tetrahydro-isochinolinen,”Arch. Pharm. 1987, 647-654, vol. 320.
Huang, et. al., “The Improved Preparation of 7,8-Dihydro-Quinoline-596H)-One And 6,7-Dihydro-5H-1-Pyrindin-5-One,”Synthetic Communications, 1998, 1197-1200, vol. 28, No. 7.
Hursthouse, et. al., “Reactions of Ethyl 2-acetyl-2-azabicyclo[2.2.1]Hept-5-ene-3-Carboxylate and 4-acetylamino-2-oxabicyclo[3.3.o]oct-7-en-3-one With Some Electrophiles,”J. Chem. Soc., 1995, 2419-2425, vol. 1.
Karanewsky, et. al., “Phosphinyloxy)acyl Amino Acid Inhibitors of Angiotensin Converting Enzyme,”J. Med. Chem., 1990, 1459-1469, vol. 33.
Ludeman, et. al., “Synthesis and Antitumor Activity of Cyclophosphamide Analogs. 1. Benzo Annulated Cyclophosphamide and Related System,” Journal of Medicinal Chemistry, 1975, 1251, vol. 18, No. 12.
Matayoshi, et. al., “Novel Fluorogenic Substrates For Assaying Retroviral Proteses by Resonance Engergy Transfer,”Science, 1990, 954-958, vol. 247.
Miller, et. al., “Preparation of Crystalline Diphenyldiazomethane,”J. Org. Chem., 1958, 560-561, vol. 24.
Mimoto, et. al., “Structure-Activity Relationship of Small-Sized HIV Protease Inhibitors Containing Allophenylnorstatine,”J. Med. Chem., 1999, 1789-1802, vol. 42.
Nagasawa, et. al., “β-Substituted Cysteines as Sequestering Agents for Ethanol-Derived Acetaldehyde in Vivo,”J. Med. Chem., 1987, 1373, vol. 30.
Nussbaumer, et. al., “Synthesis and Structure-Activity Relationships of Benzo[b]thienylallylamine Antimycotics,”Med. Chem., 1991, 65-73, vol. 34.
O'Brien, et. al., “Inhibotors of Acyl-CoA:Cholesterol )-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. Incorporation of Amide or Amine Funtionalities into a Series of Disubstituted Ureas and Carbamates. Effects on ACAT Inhibition in Vitro and Efficacy In Vivo,”J. Med. Chem., 1994, 1810-1822, vol. 37.
Onda, et. al., “Structure of Carzinophilin. II. A New Amino Acid and Its Derivative Form Carzinophillin,”Chem. Pharm. Bull., 1971, 20

Affiliated with

Also associated with

Rating

HIV protease inhibitors, compositions containing the same,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HIV protease inhibitors, compositions containing the same,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV protease inhibitors, compositions containing the same,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3704484